Biomarkers and Pharmacodynamics Analysis
Biomarkers and PD analyses precision-crafted for your studies
Developing successful therapeutics requires a deep understanding of their drug journey within the body. At PharmaLegacy, our comprehensive suite of biomarkers and pharmacodynamics (PD) analysis empowers you to decipher the intricate relationship between drug exposure, biological effects, and therapeutic response, accelerating drug development and optimizing clinical trials.
MODELS / SERVICES
- As low as 1 ug total protein, within 3 hours for 25 samples, with high repeatability
- Capillary isoelectric focusing electrophoresis (iCIEF) based protein quantification
- Quantify 3-4 proteins in one assay
- Total protein normalization, no internal reference needed
Digital LightCycler® Digital PCR system:
- The spectrum of fluorescence absorption covers the complete visible spectrum
- Excitation light: One LED light source per channel
- Excitation and emission filters for all 6 channels
Multiplex cytokines measurement by MSD, Luminex, CBA or ELISA at a dynamic range of 6 logs at most.
Multiple sample source: cell lysate, cell supernatant, serum, plasma, different tissues.
Cytometric bead array (CBA) is a flow cytometry application that allows users to quantify multiple proteins simultaneously. Compared to other quantifier assays, such as enzyme-linked immunosorbent assay (ELISA) and Western blot, CBA significantly reduces sample requirements and time to results
Committed to quality:
- FDA part 11 compliant
- Animal studies strictly follow AAALAC and ILAC guidelines
- Electronically managed, traceable research data
- Rigorous adherence to international GLP and QA best practices
- Clients have real-time remote monitoring of studies
Want your scientific discoveries to become treatments? PharmaLegacy’s the right partner for you.
Providing Better Data For Critical Oncology Pipeline Decisions
To advance a compound from discovery to clinical, or to halt its development, is a huge and costly decision. For the benefit of you and your company, and for the well-being of patients in need of treatment, that decision needs to be based on correct information.
Download our Integrated In Vitro Oncology Assays brochure and see why over 300 pharmaceutical companies, including many global leaders, trust PharmaLegacy for the unbiased, accurate information they need to make critical oncology pipeline decisions.
We’re ready when you are.
Tell us your pharmacology challenges.
